Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-04

AUTHORS

David S. Binns, Andrea Pirzkall, Wei Yu, Jason Callahan, Linda Mileshkin, Peter Conti, Andrew M. Scott, David Macfarlane, Bernard M. Fine, Rodney J. Hicks, OSI3926g Study Team

ABSTRACT

PURPOSE: The Response Evaluation Criteria in Solid Tumors (RECIST) are widely used but have recognized limitations. Molecular imaging assessments, including changes in (18)F-deoxyglucose (FDG) or (18)F-deoxythymidine (FLT) uptake by positron emission tomography (PET), may provide earlier, more robust evaluation of treatment efficacy. METHODS: A prospective trial evaluated on-treatment changes in FDG and FLT PET imaging among patients with relapsed or recurrent non-small cell lung cancer treated with erlotinib to assess the relationship between PET-evaluated response and clinical outcomes. We describe an audit of compliance with the study imaging charter, to establish the feasibility of achieving methodological consistency in a multicentre setting. RESULTS: Patients underwent PET scans at baseline and approximately day 14 and day 56 of treatment (n = 73, 66 and 51 studies, and n = 73, 63 and 50 studies for FDG PET and FLT PET, respectively). Blood glucose levels were within the target range for all FDG PET scans. Charter-specified uptake times were achieved in 86% (63/73) and 89% (65/73) of baseline FDG and FLT scans, respectively. On-treatment scans were less consistent: 72% (84/117) and 68% (77/113), respectively, achieved the target of ±5 min of baseline uptake time. However, 96% (112/117) and 94% (106/113) of FDG and FLT PET studies, respectively, were within ±15 min. Bland-Altman analysis of intra-individual hepatic average standardized uptake value (SUV(ave)), to assess reproducibility, showed only a small difference in physiological uptake (-0.006 ± 0.224 in 118 follow-up FDG scans and 0.09 ± 0.81 in 111 follow-up FLT scans). CONCLUSION: It is possible to achieve high reproducibility of scan acquisition methodology, provided that strict imaging compliance guidelines are mandated in the study protocol. More... »

PAGES

642-650

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-010-1665-0

DOI

http://dx.doi.org/10.1007/s00259-010-1665-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1025295169

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21207024


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Transport", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dideoxynucleosides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erlotinib Hydrochloride", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guideline Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Internationality", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality Control", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinazolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "The Peter MacCallum Cancer Centre, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Binns", 
        "givenName": "David S.", 
        "id": "sg:person.01213140513.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213140513.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech, Inc., South San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pirzkall", 
        "givenName": "Andrea", 
        "id": "sg:person.01363110511.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363110511.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech, Inc., South San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Wei", 
        "id": "sg:person.0632476230.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632476230.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "The Peter MacCallum Cancer Centre, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Callahan", 
        "givenName": "Jason", 
        "id": "sg:person.0616621550.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616621550.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "The Peter MacCallum Cancer Centre, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mileshkin", 
        "givenName": "Linda", 
        "id": "sg:person.01306256505.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306256505.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Southern California", 
          "id": "https://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "University of Southern California Kenneth Norris Medical Center, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Conti", 
        "givenName": "Peter", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.482095.2", 
          "name": [
            "Centre for PET, and Ludwig Institute for Cancer Research, The University of Melbourne and The Austin Hospital, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scott", 
        "givenName": "Andrew M.", 
        "id": "sg:person.010717270007.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010717270007.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Brisbane and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416100.2", 
          "name": [
            "Queensland PET Service, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Macfarlane", 
        "givenName": "David", 
        "id": "sg:person.01034455204.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034455204.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Roche (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech, Inc., South San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fine", 
        "givenName": "Bernard M.", 
        "id": "sg:person.01125330056.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125330056.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Departments of Medicine and Radiology, The University of Melbourne and The Peter MacCallum Cancer Centre, 12 St Andrew\u2019s Place, 3002, East Melbourne, VIC, Australia", 
            "The Peter MacCallum Cancer Centre, Melbourne, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hicks", 
        "givenName": "Rodney J.", 
        "id": "sg:person.01121233254.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121233254.97"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "OSI3926g Study Team", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2967/jnumed.109.063347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005078707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djj403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007567909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.108.057307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009233958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-5243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010146815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1297-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021250910", 
          "https://doi.org/10.1007/s00259-009-1297-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1297-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021250910", 
          "https://doi.org/10.1007/s00259-009-1297-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1297-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021250910", 
          "https://doi.org/10.1007/s00259-009-1297-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.108.054239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030685513"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0960-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037413540", 
          "https://doi.org/10.1007/s00259-008-0960-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042907915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042907915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(04)01564-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047268829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(99)00229-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049505783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074551522", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075309868", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075310656", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076837267", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077249105", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.23.16_suppl.3076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079369121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiology.196.1.7784562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082505950"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-04", 
    "datePublishedReg": "2011-04-01", 
    "description": "PURPOSE: The Response Evaluation Criteria in Solid Tumors (RECIST) are widely used but have recognized limitations. Molecular imaging assessments, including changes in (18)F-deoxyglucose (FDG) or (18)F-deoxythymidine (FLT) uptake by positron emission tomography (PET), may provide earlier, more robust evaluation of treatment efficacy.\nMETHODS: A prospective trial evaluated on-treatment changes in FDG and FLT PET imaging among patients with relapsed or recurrent non-small cell lung cancer treated with erlotinib to assess the relationship between PET-evaluated response and clinical outcomes. We describe an audit of compliance with the study imaging charter, to establish the feasibility of achieving methodological consistency in a multicentre setting.\nRESULTS: Patients underwent PET scans at baseline and approximately day 14 and day 56 of treatment (n\u2009=\u200973, 66 and 51 studies, and n\u2009=\u200973, 63 and 50 studies for FDG PET and FLT PET, respectively). Blood glucose levels were within the target range for all FDG PET scans. Charter-specified uptake times were achieved in 86% (63/73) and 89% (65/73) of baseline FDG and FLT scans, respectively. On-treatment scans were less consistent: 72% (84/117) and 68% (77/113), respectively, achieved the target of \u00b15\u00a0min of baseline uptake time. However, 96% (112/117) and 94% (106/113) of FDG and FLT PET studies, respectively, were within \u00b115\u00a0min. Bland-Altman analysis of intra-individual hepatic average standardized uptake value (SUV(ave)), to assess reproducibility, showed only a small difference in physiological uptake (-0.006\u2009\u00b1\u20090.224 in 118 follow-up FDG scans and 0.09\u2009\u00b1\u20090.81 in 111 follow-up FLT scans).\nCONCLUSION: It is possible to achieve high reproducibility of scan acquisition methodology, provided that strict imaging compliance guidelines are mandated in the study protocol.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00259-010-1665-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "name": "Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer", 
    "pagination": "642-650", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7881a8b3149a5b23fa96cdb8f9e44106ed7451e7ca7f629ef023bcfe2bc8fd09"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21207024"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101140988"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-010-1665-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1025295169"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-010-1665-0", 
      "https://app.dimensions.ai/details/publication/pub.1025295169"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00259-010-1665-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1665-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1665-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1665-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1665-0'


 

This table displays all metadata directly associated to this object as RDF triples.

259 TRIPLES      21 PREDICATES      62 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-010-1665-0 schema:about N21b4593a68a54793b4a4ed968fe28d04
2 N3398c324411847bb93573bc6ff047704
3 N4bc342cf46734daeb36a0efda5f90088
4 N529929b11b63433ba673d1471b4777b2
5 N5413cb24b8fe4e4c95b9b8165b654604
6 N615df2aa7c314b58bfd556798f7de88f
7 N64f5a01757af4dfa991de7d66e449cb5
8 N8fa25c5307eb44949e18d55fb7246ab1
9 N97b313ef0aa64581a9da7d31a683f73a
10 N9ad0b30ee619484cb474d3f831a274b5
11 Nb54e7a3896f54c7699d749dd0160118c
12 Nc5bc5987523740d29aae8462536f4671
13 Nc81e65684e8f4491bea2c818fcebd22d
14 Ne3e30e62b3884c20867d77e250eb97bc
15 Nf215c0f987d14415b6e515618a449a4d
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N237cb0c5195a494a89807524b9180463
19 schema:citation sg:pub.10.1007/s00259-008-0960-5
20 sg:pub.10.1007/s00259-009-1297-4
21 https://app.dimensions.ai/details/publication/pub.1074551522
22 https://app.dimensions.ai/details/publication/pub.1075309868
23 https://app.dimensions.ai/details/publication/pub.1075310656
24 https://app.dimensions.ai/details/publication/pub.1076837267
25 https://app.dimensions.ai/details/publication/pub.1077249105
26 https://doi.org/10.1016/s0959-8049(99)00229-4
27 https://doi.org/10.1016/s1470-2045(04)01564-5
28 https://doi.org/10.1056/nejmoa050753
29 https://doi.org/10.1093/jnci/92.3.205
30 https://doi.org/10.1093/jnci/djj403
31 https://doi.org/10.1148/radiology.196.1.7784562
32 https://doi.org/10.1158/1078-0432.ccr-07-5243
33 https://doi.org/10.1200/jco.2005.23.16_suppl.3076
34 https://doi.org/10.2967/jnumed.108.054239
35 https://doi.org/10.2967/jnumed.108.057307
36 https://doi.org/10.2967/jnumed.109.063347
37 schema:datePublished 2011-04
38 schema:datePublishedReg 2011-04-01
39 schema:description PURPOSE: The Response Evaluation Criteria in Solid Tumors (RECIST) are widely used but have recognized limitations. Molecular imaging assessments, including changes in (18)F-deoxyglucose (FDG) or (18)F-deoxythymidine (FLT) uptake by positron emission tomography (PET), may provide earlier, more robust evaluation of treatment efficacy. METHODS: A prospective trial evaluated on-treatment changes in FDG and FLT PET imaging among patients with relapsed or recurrent non-small cell lung cancer treated with erlotinib to assess the relationship between PET-evaluated response and clinical outcomes. We describe an audit of compliance with the study imaging charter, to establish the feasibility of achieving methodological consistency in a multicentre setting. RESULTS: Patients underwent PET scans at baseline and approximately day 14 and day 56 of treatment (n = 73, 66 and 51 studies, and n = 73, 63 and 50 studies for FDG PET and FLT PET, respectively). Blood glucose levels were within the target range for all FDG PET scans. Charter-specified uptake times were achieved in 86% (63/73) and 89% (65/73) of baseline FDG and FLT scans, respectively. On-treatment scans were less consistent: 72% (84/117) and 68% (77/113), respectively, achieved the target of ±5 min of baseline uptake time. However, 96% (112/117) and 94% (106/113) of FDG and FLT PET studies, respectively, were within ±15 min. Bland-Altman analysis of intra-individual hepatic average standardized uptake value (SUV(ave)), to assess reproducibility, showed only a small difference in physiological uptake (-0.006 ± 0.224 in 118 follow-up FDG scans and 0.09 ± 0.81 in 111 follow-up FLT scans). CONCLUSION: It is possible to achieve high reproducibility of scan acquisition methodology, provided that strict imaging compliance guidelines are mandated in the study protocol.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N3e3afe75be0a4974804226697385dfc6
44 N6d19ed96ef9b499793134b2770d29c5d
45 sg:journal.1297401
46 schema:name Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
47 schema:pagination 642-650
48 schema:productId N20ee124176734d008c922e9cfd837fe1
49 N44ee1c6b706443e38744f1aca791ee95
50 N780f82840079414084b442455442bb6c
51 Na4f86152da8945c38f73ba24fe15ea5f
52 Nc887d046a09b4ade94e9600ac3ee2c50
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025295169
54 https://doi.org/10.1007/s00259-010-1665-0
55 schema:sdDatePublished 2019-04-10T22:32
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Nd9aa5f7380de41e8919e39cfb1f39219
58 schema:url http://link.springer.com/10.1007%2Fs00259-010-1665-0
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N20ee124176734d008c922e9cfd837fe1 schema:name dimensions_id
63 schema:value pub.1025295169
64 rdf:type schema:PropertyValue
65 N21b4593a68a54793b4a4ed968fe28d04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Feasibility Studies
67 rdf:type schema:DefinedTerm
68 N237cb0c5195a494a89807524b9180463 rdf:first sg:person.01213140513.69
69 rdf:rest N9b1cdaa17b9c4961ae56546f65bb37be
70 N3398c324411847bb93573bc6ff047704 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Humans
72 rdf:type schema:DefinedTerm
73 N3e3afe75be0a4974804226697385dfc6 schema:issueNumber 4
74 rdf:type schema:PublicationIssue
75 N44ee1c6b706443e38744f1aca791ee95 schema:name readcube_id
76 schema:value 7881a8b3149a5b23fa96cdb8f9e44106ed7451e7ca7f629ef023bcfe2bc8fd09
77 rdf:type schema:PropertyValue
78 N4bc342cf46734daeb36a0efda5f90088 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Guideline Adherence
80 rdf:type schema:DefinedTerm
81 N520b71541e68493bbfd6f8e208c133c5 rdf:first sg:person.01306256505.25
82 rdf:rest N58dee1159f6347bca4cd758c3f5db9e4
83 N529929b11b63433ba673d1471b4777b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Internationality
85 rdf:type schema:DefinedTerm
86 N5413cb24b8fe4e4c95b9b8165b654604 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Biological Transport
88 rdf:type schema:DefinedTerm
89 N5578605056674cce8967356ff5cba1fc rdf:first N851d7c8e96564d85aaaa5d5f2653d50d
90 rdf:rest rdf:nil
91 N58dee1159f6347bca4cd758c3f5db9e4 rdf:first N59bcf12313ed4afaa8a41d0b0cd86069
92 rdf:rest N7129b75971174f6088783e9b556789c1
93 N59bcf12313ed4afaa8a41d0b0cd86069 schema:affiliation https://www.grid.ac/institutes/grid.42505.36
94 schema:familyName Conti
95 schema:givenName Peter
96 rdf:type schema:Person
97 N615df2aa7c314b58bfd556798f7de88f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Erlotinib Hydrochloride
99 rdf:type schema:DefinedTerm
100 N61cfc989834243638d213e4e149e8b89 rdf:first sg:person.01121233254.97
101 rdf:rest N5578605056674cce8967356ff5cba1fc
102 N64f5a01757af4dfa991de7d66e449cb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Dideoxynucleosides
104 rdf:type schema:DefinedTerm
105 N6d19ed96ef9b499793134b2770d29c5d schema:volumeNumber 38
106 rdf:type schema:PublicationVolume
107 N7129b75971174f6088783e9b556789c1 rdf:first sg:person.010717270007.67
108 rdf:rest N8bb440f8643942e6981fc6307d4be5f3
109 N780f82840079414084b442455442bb6c schema:name nlm_unique_id
110 schema:value 101140988
111 rdf:type schema:PropertyValue
112 N851d7c8e96564d85aaaa5d5f2653d50d schema:familyName OSI3926g Study Team
113 rdf:type schema:Person
114 N8bb440f8643942e6981fc6307d4be5f3 rdf:first sg:person.01034455204.78
115 rdf:rest Nee165f391fe64029b31a6803577d0947
116 N8fa25c5307eb44949e18d55fb7246ab1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Positron-Emission Tomography
118 rdf:type schema:DefinedTerm
119 N97b313ef0aa64581a9da7d31a683f73a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Lung Neoplasms
121 rdf:type schema:DefinedTerm
122 N9ad0b30ee619484cb474d3f831a274b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Quality Control
124 rdf:type schema:DefinedTerm
125 N9b1cdaa17b9c4961ae56546f65bb37be rdf:first sg:person.01363110511.55
126 rdf:rest Nd7c685c85b254ecf88936e7d5e352f79
127 Na4f86152da8945c38f73ba24fe15ea5f schema:name doi
128 schema:value 10.1007/s00259-010-1665-0
129 rdf:type schema:PropertyValue
130 Nad20357549e24a23a15f8b815ed5ae26 rdf:first sg:person.0616621550.24
131 rdf:rest N520b71541e68493bbfd6f8e208c133c5
132 Nb54e7a3896f54c7699d749dd0160118c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Blood Glucose
134 rdf:type schema:DefinedTerm
135 Nc5bc5987523740d29aae8462536f4671 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Treatment Outcome
137 rdf:type schema:DefinedTerm
138 Nc81e65684e8f4491bea2c818fcebd22d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Quinazolines
140 rdf:type schema:DefinedTerm
141 Nc887d046a09b4ade94e9600ac3ee2c50 schema:name pubmed_id
142 schema:value 21207024
143 rdf:type schema:PropertyValue
144 Nd7c685c85b254ecf88936e7d5e352f79 rdf:first sg:person.0632476230.29
145 rdf:rest Nad20357549e24a23a15f8b815ed5ae26
146 Nd9aa5f7380de41e8919e39cfb1f39219 schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 Ne3e30e62b3884c20867d77e250eb97bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Carcinoma, Non-Small-Cell Lung
150 rdf:type schema:DefinedTerm
151 Nee165f391fe64029b31a6803577d0947 rdf:first sg:person.01125330056.18
152 rdf:rest N61cfc989834243638d213e4e149e8b89
153 Nf215c0f987d14415b6e515618a449a4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Fluorodeoxyglucose F18
155 rdf:type schema:DefinedTerm
156 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
157 schema:name Medical and Health Sciences
158 rdf:type schema:DefinedTerm
159 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
160 schema:name Clinical Sciences
161 rdf:type schema:DefinedTerm
162 sg:journal.1297401 schema:issn 1619-7070
163 1619-7089
164 schema:name European Journal of Nuclear Medicine and Molecular Imaging
165 rdf:type schema:Periodical
166 sg:person.01034455204.78 schema:affiliation https://www.grid.ac/institutes/grid.416100.2
167 schema:familyName Macfarlane
168 schema:givenName David
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034455204.78
170 rdf:type schema:Person
171 sg:person.010717270007.67 schema:affiliation https://www.grid.ac/institutes/grid.482095.2
172 schema:familyName Scott
173 schema:givenName Andrew M.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010717270007.67
175 rdf:type schema:Person
176 sg:person.01121233254.97 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
177 schema:familyName Hicks
178 schema:givenName Rodney J.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121233254.97
180 rdf:type schema:Person
181 sg:person.01125330056.18 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
182 schema:familyName Fine
183 schema:givenName Bernard M.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125330056.18
185 rdf:type schema:Person
186 sg:person.01213140513.69 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
187 schema:familyName Binns
188 schema:givenName David S.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213140513.69
190 rdf:type schema:Person
191 sg:person.01306256505.25 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
192 schema:familyName Mileshkin
193 schema:givenName Linda
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306256505.25
195 rdf:type schema:Person
196 sg:person.01363110511.55 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
197 schema:familyName Pirzkall
198 schema:givenName Andrea
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363110511.55
200 rdf:type schema:Person
201 sg:person.0616621550.24 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
202 schema:familyName Callahan
203 schema:givenName Jason
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616621550.24
205 rdf:type schema:Person
206 sg:person.0632476230.29 schema:affiliation https://www.grid.ac/institutes/grid.418158.1
207 schema:familyName Yu
208 schema:givenName Wei
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632476230.29
210 rdf:type schema:Person
211 sg:pub.10.1007/s00259-008-0960-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037413540
212 https://doi.org/10.1007/s00259-008-0960-5
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/s00259-009-1297-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021250910
215 https://doi.org/10.1007/s00259-009-1297-4
216 rdf:type schema:CreativeWork
217 https://app.dimensions.ai/details/publication/pub.1074551522 schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1075309868 schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1075310656 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1076837267 schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1077249105 schema:CreativeWork
222 https://doi.org/10.1016/s0959-8049(99)00229-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049505783
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/s1470-2045(04)01564-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047268829
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1056/nejmoa050753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042907915
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1093/jnci/djj403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007567909
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1148/radiology.196.1.7784562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082505950
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1158/1078-0432.ccr-07-5243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010146815
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2005.23.16_suppl.3076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079369121
237 rdf:type schema:CreativeWork
238 https://doi.org/10.2967/jnumed.108.054239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030685513
239 rdf:type schema:CreativeWork
240 https://doi.org/10.2967/jnumed.108.057307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009233958
241 rdf:type schema:CreativeWork
242 https://doi.org/10.2967/jnumed.109.063347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005078707
243 rdf:type schema:CreativeWork
244 https://www.grid.ac/institutes/grid.1055.1 schema:alternateName Peter MacCallum Cancer Centre
245 schema:name Departments of Medicine and Radiology, The University of Melbourne and The Peter MacCallum Cancer Centre, 12 St Andrew’s Place, 3002, East Melbourne, VIC, Australia
246 The Peter MacCallum Cancer Centre, Melbourne, Australia
247 rdf:type schema:Organization
248 https://www.grid.ac/institutes/grid.416100.2 schema:alternateName Royal Brisbane and Women's Hospital
249 schema:name Queensland PET Service, Royal Brisbane and Women’s Hospital, Brisbane, Australia
250 rdf:type schema:Organization
251 https://www.grid.ac/institutes/grid.418158.1 schema:alternateName Roche (United States)
252 schema:name Genentech, Inc., South San Francisco, CA, USA
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.42505.36 schema:alternateName University of Southern California
255 schema:name University of Southern California Kenneth Norris Medical Center, Los Angeles, CA, USA
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.482095.2 schema:alternateName Ludwig Institute for Cancer Research
258 schema:name Centre for PET, and Ludwig Institute for Cancer Research, The University of Melbourne and The Austin Hospital, Victoria, Australia
259 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...